Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1Phase 2 1

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 4NIH 1INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Plasma cell 4Myeloid 2Lymphoid 2Classical hematology 2Other hematologic neoplasm 1

Conditions

Lymphoma 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Leukemia 17Lymphoma, Non-Hodgkin 16Sarcoma 9Leukemia, Myeloid, Acute 9Hodgkin Disease 9Hematologic Neoplasms 9Neuroblastoma 8Neoplasms 8Myelodysplastic Syndromes 7Leukemia, Lymphocytic, Chronic, B-Cell 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Burkitt Lymphoma 6Osteosarcoma 5Melanoma 5Lymphoma, Mantle-Cell 5Lymphoma, Follicular 5Breast Neoplasms 5Rhabdoid Tumor 4Retinoblastoma 4Multiple Myeloma 4Medulloblastoma 4Lymphoma, Large B-Cell, Diffuse 4Wilms Tumor 3Recurrence 3Neoplasms, Germ Cell and Embryonal 3Myeloproliferative Disorders 3Hepatoblastoma 3Graft vs Host Disease 3

Interventions

Dexamethasone 420Lenalidomide 265Cyclophosphamide 246Bortezomib 242Melphalan 192Calcium Dobesilate 166fludarabine phosphate 112daratumumab 103Peripheral Blood Stem Cell Transplantation 99carfilzomib 92Thalidomide 90Filgrastim 88Mycophenolic Acid 82fludarabine 81pomalidomide 80Whole-Body Irradiation 80Busulfan 74Tacrolimus 71Granulocyte Colony-Stimulating Factor 66Cyclosporine 58dexamethasone acetate 56ixazomib 55Antilymphocyte Serum 50dexamethasone 21-phosphate 49auricularum 44isatuximab 40Etoposide 39Radiotherapy 36Stem Cell Transplantation 34Methotrexate 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Multiple Myeloma × Mesna × Clear all
NCT03016806 2025-10-10

Umbilical Cord Blood Transplantation From Unrelated Donors

University of Rochester

Recruiting
30 enrolled
Classical hematologyLymphoidMyeloidPlasma cell

Anemia, Aplastic, Immunologic Deficiency Syndromes, Lymphoma, Metabolic Diseases, Multiple Myeloma, Myelodysplastic Syndromes

NCT00177047 2021-11-09

Autologous Transplant for Multiple Myeloma

Masonic Cancer Center, University of Minnesota

Phase 2/3 Completed
363 enrolled 25 charts
Plasma cell

Multiple Myeloma

NCT01010217 2020-03-25

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

M.D. Anderson Cancer Center

Phase 2 Completed
176 enrolled 18 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hematologic Diseases, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01731886 2020-02-05

Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma

Columbia University

Phase 4 Completed
60 enrolled 14 charts
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡